4//SEC Filing
Abate Kristin 4
Accession 0000950170-25-097965
CIK 0001503802other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 5:18 PM ET
Size
4.9 KB
Accession
0000950170-25-097965
Insider Transaction Report
Form 4
Abate Kristin
Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-07-22$4.00/sh−238$952→ 9,475 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0002045943
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 5:18 PM ET
- Size
- 4.9 KB